Will SpiMed-AI receive FDA clearance for CorEx by December 1, 2023?
19
Ṁ390Ṁ3.9kresolved Nov 30
Resolved
NO1H
6H
1D
1W
1M
ALL
SpiMed-AI is a French company that develops medical imaging AI for cardiologists. SpiMed-AI CorEx is the company's flagship product and according to their website they expect to receive FDA clearance during 2023. This market resolves YES if SpiMed-AI has been awarded FDA 510k clearance by December 1, 2023.
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000🏅 Top traders
| # | Trader | Total profit |
|---|---|---|
| 1 | Ṁ280 | |
| 2 | Ṁ36 | |
| 3 | Ṁ29 | |
| 4 | Ṁ5 | |
| 5 | Ṁ3 |
